Abstract:Lung cancer is the leading cause of cancer death worldwide, and squamous carcinoma is the most common histological subtype. Clinical and molecular evidence indicated that lung squamous carcinoma is heterogeneous disease. Long non-coding RNAs (lncRNAs) were noncoding RNAs with more than 200 nucleotide length. They have been found to be involved in a variety of biological processes. Many studies indicated that they were aberrantly expressed in some types of carcinomas. In this study, we tested the hypothesis that some lncRNAs may correlate with lung cancer tumor genesis by detecting genome-scale lncRNAs expressions. 16 lung squamous cell carcinoma patients’paired normal and lung tumor tissues were obtained after surgery. First, extracted total RNA from frozen tissues by Trizol reagent; next, reverse-transcripted the total RNA to cDNA, got cRNA in vitro transcription synthesis, and then purified cRNA by spin columns, cRNA was transcribed into cDNA utilizing a random priming method and cDNA was labeled and hybridized to the Agilent human 4×180 K microarray. Processed signal data was obtained from hybridized images using Agilent Feature Extraction. Quantile normalization and differential expression data were performed using the Agilent GeneSpring. Data analyses were performed using R and Bioconductor. With abundant and varied probes accounting 38,361 lncRNAs in our microarray, the number of lncRNAs that expressed at a certain level could be detected is 28,055. From the results we found that there were 3,460 lncRNAs that differentially expressed (≥ 2 absolute fold-change) in lung squamous cell carcinoma tissues compared with normal tissue, among which 127 lncRNAs differentially expressed in all 16 lung squamous cell carcinoma samples. Our study is the first one to determine genome-wide lncRNAs expression patterns in lung squamous cell carcinoma by using microarray. The results indicated that clusters of lncRNAs were significantly differentially expressed. Of all 3,460 differentially expressed lncRNAs, 1901 lncRNAs were up-regulated and 1559 down-regulated. 9/16 lung squamous cell carcinoma patients’up-regulated lncRNAs were more common than down-regulated ones. 7/16 patients down-regulated lncRNAs were more common than up-regulated ones. To predict the functions of lncRNAs, we constructed coding–non-coding gene co-expression networks of lncRNAs and mRNAs, on the basic of correlation cutoff 0.99 and P-value<0.05. We searched lncRNAmRNA pairs whose distance of genomic locations was less than 10kb. In addition, we blatted the sequences of lncRNA and 3‘UTR of mRNAs to screen the sequence similarity lncRNA-mRNA pairs. We then got 33 lncRNA-mRNA pairs. The mRNAs of pairs were considered the target genes of lncRNAs. From the mRNAs, we found that TERC was likely a useful biomarker for the diagnosis of the non-small cell carcinoma. As the ENST00000363312 and sno-RNA_scaRNA_0_548 also had the similar function, we considered that they were likely useful biomarkers for the diagnosis of the non-small cell carcinoma. We concluded that lncRNAs differentially expressed in lung tumor tissues and normal tissues may exert a partial or key role in lung tumor development, and may provide potential targets for future treatment of lung squamous cell carcinoma.

Characterization of Microrna Transcriptome in Tumor, Adjacent, and Normal Tissues of Lung Squamous Cell Carcinoma.

Identification of Stage-associated MicroRNAs in Lung Adenocarcinoma Based on Microarray Data

Differentially Expressed Mirnas in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma.

Identification Of Mir-133a-3p-Expression Signature And Probable Mechanism In Lung Squamous Cell Carcinoma: Insights From Integrated Analysis

Characterization of Micrornas and Lncrnas in Early-Stage Squamous Cell Carcinoma Based on the Analysis of TCGA Datasets

In-depth Bioinformatic Analysis of Lung Cancer-Associated Microrna Targets

Involvement of Micrornas in Lung Cancer Biology and Therapy

Genome-scale lncRNAs Expressions Pattern in Lung Squamous Carcinoma

Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma.

Diagnosis Value of Aberrantly Expressed Microrna Profiles in Lung Squamous Cell Carcinoma: a Study Based on the Cancer Genome Atlas

Deep Sequencing Reveals Complex Mechanisms of Microrna Deregulation in Colorectal Cancer

Advances of Microrna in Lung Cancer

Comprehensive Analysis of Hsa-Mir-654-5p's Tumor-Suppressing Functions

MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs

Research Progress on Lung Cancer Related MicroRNAs

In Situ Measurement of Mir-138 Expression in Oral Squamous Cell Carcinoma Tissue Supports the Role of This Microrna As a Tumor Suppressor

Comprehensive Investigation of Aberrant Microrna Profiling in Bladder Cancer Tissues.

MicroRNA-218 Functions As a Tumor Suppressor in Lung Cancer by Targeting IL-6/STAT3 and Negatively Correlates with Poor Prognosis

A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma

Systematic analysis reveals key microRNAs as diagnostic and prognostic factors in progressive stages of lung cancer

MicroRNA Expression Profiles Predict Progression and Clinical Outcome in Lung Adenocarcinoma